Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV90

GWQ ServicePlus AG is seeking to conclude non-exclusive discount agreements for patent-protected active pharmaceutical ingredients under German social security law (§130a Abs. 8 SGB V). This is a German pharmaceutical procurement for negotiated pricing on branded drugs, requiring suppliers to be authorized pharmaceutical manufacturers or distributors with valid German market authorization. The contract value is not specified, but typically involves framework agreements for drug supply to German statutory health insurance schemes.